Aranscia® solutions help oncologists comply with new FDA warning label requiring DPYD genetic testing in patients receiving select chemotherapies HOUSTON, Oct. 16, 2025 /PRNewswire/ — Oncologists and pharmacy experts are reacting to last week’s Food and Drug Administration warning that requires genetic testing … Read More
News
Spartanburg Regional Healthcare System (SRHS) Deploys 2bPrecise Enterprise
Multi-year partnership affirms SRHS as a leader in precision care and genomics SPARTANBURG, S.C. and HOUSTON, June 25, 2025 /PRNewswire/ — Spartanburg Regional Healthcare System (SRHS) today announced its deployment of the 2bPrecise® enterprise platform. Under this multi-year partnership, 2bPrecise-powered applications are now … Read More
Tags: Spartanburg, SRHS
Neurogen Biomarking Announces Partnership with Aranscia
Aranscia Diagnostic Laboratory and Technology Solutions Support Neurogen’s Innovative Platform for the Early Detection of Mild Cognitive Impairment (MCI) and Alzheimer’s Dementia CHICAGO and HOUSTON, May 21, 2025 /PRNewswire/ — Neurogen Biomarking, the world’s first ecosystem for memory loss with … Read More
PGx Biomarker Testing: Covered Soon for All Californians
Good news for CA providers and residents! Starting July 1, 2024, Pharmacogenomic (PGx) biomarker testing will be a covered benefit for all Californians*, regardless of insurance provider. PGx testing is already a covered benefit for Medicare patients. Read the press … Read More
2bPrecise Named “Best Overall Genomics Company” in 2023 MedTech Breakthrough Awards Program
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies [Houston, TX] – May 3, 2023 – 2bPrecise, a leading provider of transformative precision medicine solutions, today announced that it is the recipient … Read More
Tags: MedTech, MedTech Breakthrough
2bPrecise Named “Best Overall Genomics Company” in 2022 MedTech Breakthrough Awards Program
Prestigious Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies PITTSBURGH, PA, – May 5, 2022 – 2bPrecise, a leading provider of transformative precision medicine solutions, today announced that it has been selected as the winner of … Read More
2bPrecise Joins the Epic App Orchard to Bring Its Precision Medicine Insights to the Point of Care
Platform delivers genetic/genomic data directly into the EHR workflow for Epic customers Raleigh, NC – Nov. 3, 2021 – 2bPrecise™ announced its Precision Health™ platform is now available in the Epic App Orchard Gallery. The App Orchard program enables developers … Read More
AccessDX Holdings acquires 2bPrecise
Combined capabilities create industry’s most advanced precision medicine enablement solution PITTSBURGH and HOUSTON – Aug. 25, 2021 – AccessDX Holdings, an international provider of advanced laboratory diagnostic solutions, has acquired 2bPrecise™ from Allscripts Healthcare Solutions. A recognized leader and innovator … Read More
2bPrecise Deepens Oncology Functionality, Introduces Automation to Identify Medication Safety Risk in Polypharmacy Patients
Summer 2021 product features customer-driven enhancements, including patient-directed family history documentation, and strengthens infrastructure for greater scalability RALIEGH, NC – July 27, 2021 – 2bPrecise, an EHR-agnostic, cloud-based precision medicine platform, announced it delivered advanced and innovative functionality to clients … Read More
US Orthopedic Alliance Selects 2bPrecise To Accelerate Precision Medicine Program
Partnership will enable member orthopedic surgeons to identify potential drug-gene interactions to improve the patient experience and outcomes RALEIGH, N.C. and LAKE FOREST, Calif. – May 24, 2021 – US Orthopedic Alliance (USOA) has selected 2bPrecise to provide its precision … Read More